glutamic acid has been researched along with MPTP Neurotoxicity Syndrome in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (43.75) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, A; Lu, M; Wang, R; Wen, Y; Xu, J; Zhao, X; Zhou, J | 1 |
Bi, GH; Bonci, A; Chen, K; De Biase, LM; Lee, PT; Liang, Y; Madeo, G; Marino, RAM; McDevitt, RA; Shen, H; Su, TP; Xi, ZX | 1 |
Gong, D; Guo, C; Li, X; Liu, H; Qi, L; Qu, H; Xue, X | 1 |
Ansah, TA; Ferguson, MC; Nayyar, T | 1 |
Hood, RL; Meshul, CK; Mitchell, SH; Pflibsen, L; Sconce, MD; Stang, KA; Wilson, VB | 1 |
Bagga, P; Crescenzi, R; Detre, JA; Greenberg, J; Hariharan, H; Krishnamoorthy, G; Nanga, RP; Reddy, D; Reddy, R; Verma, G | 1 |
Brekke, L; Ebadi, M; Sangchot, P; Sharma, S; Shavali, S | 1 |
Alessandrí, MG; Fornai, F; Geppert, M; Jahn, R; Schlüter, OM; Südhof, TC; Takamori, S | 1 |
Bonuccelli, U; Corsini, GU; Maggio, R; Pardini, C; Vaglini, F | 1 |
Greenberg, DA | 1 |
Greenamyre, JT | 1 |
Cano, J; Machado, A; Matarredona, ER; Santiago, M | 1 |
Colpaert, F; Cosi, C; Degryse, A; Facci, L; Kanai, Y; Koek, W; Marien, MR; Menegazzi, M; Milani, D; Skaper, SD; Suzuki, H; Vantini, G | 1 |
Beal, MF; Becker, DA; Klivenyi, P; MacGarvey, U; Matthews, RT; Natero, R; Wermer, M; Yang, L | 1 |
Beal, MF | 1 |
Aschner, M; Kimelberg, HK | 1 |
4 review(s) available for glutamic acid and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Glutamate and Parkinson's disease.
Topics: Animals; Brain; Glutamates; Glutamic Acid; Humans; MPTP Poisoning; Parkinson Disease; Parkinson Disease, Secondary; Synaptic Transmission | 1994 |
Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Agents; Drug Evaluation, Preclinical; Drug Synergism; Drug Tolerance; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Haplorhini; Humans; Mice; MPTP Poisoning; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Quinoxalines; Rats; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1993 |
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Topics: Aging; Alzheimer Disease; Animals; Brain Diseases; Cell Death; Energy Metabolism; Glutamates; Glutamic Acid; Humans; Huntington Disease; Ion Channel Gating; Mitochondria; Models, Biological; MPTP Poisoning; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Phosphorylation; Parkinson Disease; Parkinson Disease, Secondary; Primates; Rats; Receptors, N-Methyl-D-Aspartate | 1992 |
The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury.
Topics: Ammonia; Animals; Astrocytes; Cells, Cultured; Glutamates; Glutamic Acid; Huntington Disease; Metals; Models, Neurological; MPTP Poisoning; Nerve Degeneration; Nervous System | 1991 |
12 other study(ies) available for glutamic acid and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Transport System X-AG; Animals; Astrocytes; Carrier Proteins; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Excitatory Amino Acid Transporter 2; Gene Knockout Techniques; Glial Fibrillary Acidic Protein; Glutamic Acid; Heat-Shock Proteins; Male; Membrane Transport Proteins; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; MPTP Poisoning; Neurogenesis; Neurotoxins; Paraquat; Phosphatidylinositol 3-Kinases; STAT3 Transcription Factor | 2018 |
Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice.
Topics: Animals; Brain-Derived Neurotrophic Factor; Dopaminergic Neurons; Electrophysiological Phenomena; Gene Expression Regulation; Glutamic Acid; Male; Membrane Glycoproteins; Mice; Motor Activity; MPTP Poisoning; Mutation; Protein-Tyrosine Kinases; Vesicular Glutamate Transport Protein 2 | 2018 |
Baicalein ameliorated the upregulation of striatal glutamatergic transmission in the mice model of Parkinson's disease.
Topics: Animals; Corpus Striatum; Cytokines; Disease Models, Animal; Flavanones; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Receptors, AMPA; Synaptic Transmission; Up-Regulation | 2014 |
Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.
Topics: Animals; Extracellular Space; Fluorobenzenes; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Microdialysis; MPTP Poisoning; Neostriatum; Parkinson Disease, Secondary; Piperidines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Synaptosomes | 2014 |
Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Brain; Cognition Disorders; Disease Models, Animal; Executive Function; Gait Disorders, Neurologic; Gene Expression Regulation; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neuropsychological Tests; Tyrosine 3-Monooxygenase; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2 | 2015 |
Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Astrocytes; Brain Chemistry; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Glial Fibrillary Acidic Protein; Gliosis; Glutamic Acid; Hand Strength; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Tyrosine 3-Monooxygenase; Vesicular Glutamate Transport Protein 1 | 2016 |
The multiple actions of selegiline.
Topics: Animals; Antiparkinson Agents; Cells, Cultured; Dopamine; Female; Glutamic Acid; Mesencephalon; Monoamine Oxidase Inhibitors; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease; Pregnancy; Rats; Rats, Sprague-Dawley; Selegiline | 2002 |
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; alpha-Synuclein; Animals; Antibodies; Blastomeres; Blotting, Southern; Corpus Striatum; Disease Models, Animal; DNA Primers; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hippocampus; Homovanillic Acid; Humans; Immunoblotting; Immunohistochemistry; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Parkinsonian Disorders; Piperazines; Rats; Reserpine; Serotonin; Stem Cells; Subcellular Fractions; Substantia Nigra; Synucleins; Tyrosine 3-Monooxygenase | 2003 |
Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Chelating Agents; Dextromethorphan; Ditiocarb; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Homovanillic Acid; Male; Mesencephalon; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Septal Nuclei; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase | 2003 |
Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acids, Essential; Animals; Ascorbic Acid; Aspartic Acid; Dicarboxylic Acids; Dopamine; Dopamine Agents; Extracellular Space; Glutamic Acid; Immunohistochemistry; Male; Microdialysis; MPTP Poisoning; Neostriatum; Nerve Endings; Neurotransmitter Uptake Inhibitors; Pyrrolidines; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 1997 |
Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agents.
Topics: Animals; Benzamides; Benzoates; Benzoic Acid; Brain; Catecholamines; Cell Survival; Cells, Cultured; Cerebellum; Dopamine; Enzyme Inhibitors; Glutamic Acid; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Neuroprotective Agents; Neurotoxins; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; RNA, Messenger; Transcription, Genetic | 1997 |
Azulenyl nitrone spin traps protect against MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Azulenes; Brain Chemistry; Dopamine; Free Radicals; Glutamic Acid; Male; Mice; MPTP Poisoning; N-Methylaspartate; Neuroprotective Agents; Nitrogen Oxides; Oxidation-Reduction; Sesquiterpenes; Spin Labels | 1998 |